Cue Biopharma, Inc. (CUE)
27.82
+5.49
(+24.59%)
USD |
NASDAQ |
Oct 09, 16:00
27.87
+0.05
(+0.18%)
After-Hours: 20:00
Cue Biopharma Market Cap : 145.48M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 116.77M |
| October 07, 2026 | 117.71M |
| October 06, 2026 | 121.01M |
| October 05, 2026 | 127.39M |
| October 02, 2026 | 133.72M |
| October 01, 2026 | 132.04M |
| September 30, 2026 | 135.28M |
| September 29, 2026 | 133.40M |
| September 28, 2026 | 143.55M |
| September 25, 2026 | 164.26M |
| September 24, 2026 | 171.79M |
| September 23, 2026 | 165.82M |
| September 22, 2026 | 161.59M |
| September 21, 2026 | 147.84M |
| September 18, 2026 | 193.75M |
| September 17, 2026 | 197.88M |
| September 16, 2026 | 178.69M |
| September 15, 2026 | 165.46M |
| September 14, 2026 | 159.76M |
| September 11, 2026 | 150.29M |
| September 10, 2026 | 146.42M |
| September 09, 2026 | 159.50M |
| September 08, 2026 | 156.88M |
| September 04, 2026 | 143.49M |
| September 03, 2026 | 144.70M |
| Date | Value |
|---|---|
| September 02, 2026 | 140.98M |
| September 01, 2026 | 148.72M |
| August 31, 2026 | 133.45M |
| August 28, 2026 | 145.80M |
| August 27, 2026 | 147.26M |
| August 26, 2026 | 150.87M |
| August 25, 2026 | 139.94M |
| August 24, 2026 | 121.22M |
| August 21, 2026 | 125.40M |
| August 20, 2026 | 128.70M |
| August 19, 2026 | 137.43M |
| August 18, 2026 | 134.40M |
| August 17, 2026 | 144.54M |
| August 14, 2026 | 178.85M |
| August 13, 2026 | 162.53M |
| August 12, 2026 | 159.08M |
| August 11, 2026 | 147.68M |
| August 10, 2026 | 84.97M |
| August 07, 2026 | 88.29M |
| August 06, 2026 | 87.93M |
| August 05, 2026 | 86.76M |
| August 04, 2026 | 86.59M |
| August 03, 2026 | 87.47M |
| July 31, 2026 | 87.37M |
| July 30, 2026 | 98.96M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xilio Therapeutics, Inc. | 59.75M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.10B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.012B |
Market Cap Related Metrics
| PS Ratio | 3.361 |
| PEG Ratio | -0.0035 |
| Price to Book Value | 62.98 |
| Price | 27.82 |
| Earnings Yield | -97.06% |
| PEGY Ratio | -0.0035 |